Betamethasone Dipropionate/Calcipotriol

倍他米松二丙酸酯/卡泊三醇

Report date: 2026/04/13 20:02:18

Base Information

Drug NameBetamethasone Dipropionate/Calcipotriol
Drug Alias NameBetamethasone dipropionate/calcipotriol - MC2 TherapeuticsMC2-01乳膏BDP/calcipotriene - MC2 BiotekPADscalpWynzora +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionVitamin D receptor antagonistsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorVitamin D receptor
Therapy Area/IndicationsPlaque psoriasisPsoriasisDermatitis, Phototoxic +[4] 
Global Approved IndicationsPlaque psoriasisPsoriasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2006/01/09
Country/TerritoryCzechiaUnited StatesGermany +[7] 
CombinationsYes
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesMc2 Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires ChemineauMC2 Therapeutics Pty LtdEPI Health LLC +[7] 
Inactive CompaniesLeo Pharma Inc
Active IndicationsPlaque psoriasisPsoriasis
Inactive IndicationsDermatitis, PhototoxicDermatitis, Photoallergic

Other Information

ATC CodeD05AX52
Related LinksN/A